Australian Institute of Health and Welfare (2022) Health expenditure Australia 2020-21, AIHW, Australian Government, accessed 30 November 2022.
Australian Institute of Health and Welfare. (2022). Health expenditure Australia 2020-21. Retrieved from https://www.aihw.gov.au/reports/health-welfare-expenditure/health-expenditure-australia-2020-21
Health expenditure Australia 2020-21. Australian Institute of Health and Welfare, 23 November 2022, https://www.aihw.gov.au/reports/health-welfare-expenditure/health-expenditure-australia-2020-21
Australian Institute of Health and Welfare. Health expenditure Australia 2020-21 [Internet]. Canberra: Australian Institute of Health and Welfare, 2022 [cited 2022 Nov. 30]. Available from: https://www.aihw.gov.au/reports/health-welfare-expenditure/health-expenditure-australia-2020-21
Australian Institute of Health and Welfare (AIHW) 2022, Health expenditure Australia 2020-21, viewed 30 November 2022, https://www.aihw.gov.au/reports/health-welfare-expenditure/health-expenditure-australia-2020-21
Get citations as an Endnote file:
PDF | 7.3Mb
State and territory governments manage and administer the public hospital system as well as many other health goods and services. These goods and services are financed by a combination of their own funding (column F), as well as funds from the Australian Government and non-government sources.
The major sources of data on spending on most health activities by state and territory governments are supplied through the GHE NMDS, which includes 3 main tables:
Data from GHE NMDS ‘Gross expenditure’ for each state and territory are mapped with areas of expenditure based on the organisation type, and assigned to the following areas:
GHE NMDS ‘Gross expenditure’ includes capital depreciation. Prior to 2019–20, depreciation of capital data from ABS statistics were used instead of the figures from GHE NMDS ‘Depreciation’. The ABS depreciation was allocated on the basis of the depreciation proportion by organisation function from the GHE NMDS. Since 2019–20, since the ABS depreciation data did not take into account the accounting standard changes related to leases (AASB, 2016), depreciation data in Table 4 GHE NMDS are used instead.
State and territory capital expenditure (row 36, data from ABS Government GFCF) and expenditure funded by state and territory governments on health research (rows 31 and 32, data from ABS Research and Experimental Development statistics) are added to complete the gross expenditure components.
Revenue computed for each area of spending are offset against the respective gross expenditure in each area. Data for revenue in GHE NMDS ‘Gross expenditure’ are not collected by function codes, therefore revenue data are allocated across functions (areas of expenditure) based on the proportions of gross expenditure in each organisation type. This results in a distribution of revenue for each area of spending.
Revenue from the Australian Government and non-government sources are offset against state and territory spending, including:
There are no offsets from states and territories (column F) to other expenditure sources (other columns). However, revenues from specific sources (GHE NMDS ‘Revenue’) are used to determine the health expenditure in relevant columns, such as:
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.